Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 2
2018 2
2019 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry.
Štefániková M, Doubková M, Ovesná P, Šterclová M, Lacina L, Žurková M, Plačková M, Bartoš V, Janíčková I, Bittenglová R, Anton J, Sýkorová Ľ, Lošťáková V, Musilová P, Šuldová H, Mokošová R, Didyk J, Šišáková L, Lisá P, Lněnička J, Dařičková H, Doležel D, Pšikalová J, Tyl R, Králová R, Vašáková MK. Štefániková M, et al. Among authors: lostakova v. BMC Pulm Med. 2023 May 3;23(1):154. doi: 10.1186/s12890-023-02450-3. BMC Pulm Med. 2023. PMID: 37138274 Free PMC article.
DSP rs2076295 variants influence nintedanib and pirfenidone outcomes in idiopathic pulmonary fibrosis: a pilot study.
Doubkova M, Kriegova E, Littnerova S, Schneiderova P, Sterclova M, Bartos V, Plackova M, Zurkova M, Bittenglova R, Lostaková V, Siskova L, Lisa P, Suldova H, Doubek M, Psikalova J, Snizek T, Musilova P, Vasakova M. Doubkova M, et al. Among authors: lostakova v. Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211042529. doi: 10.1177/17534666211042529. Ther Adv Respir Dis. 2021. PMID: 34515605 Free PMC article.
[Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry].
Doubková M, Uher M, Bartoš V, Šterclová M, Lacina L, Lošťáková V, Binková I, Plačková M, Žurková M, Bittenglová R, Pšikalová J, Šišková L, Lisá P, Petřík F, Polák J, Řihák V, Skřičková J, Vašáková M. Doubková M, et al. Among authors: lostakova v. Cas Lek Cesk. 2016;155(4):22-8. Cas Lek Cesk. 2016. PMID: 27481198 Czech.
EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
Doubková M, Švancara J, Svoboda M, Šterclová M, Bartoš V, Plačková M, Lacina L, Žurková M, Binková I, Bittenglová R, Lošťáková V, Merta Z, Šišková L, Tyl R, Lisá P, Šuldová H, Petřík F, Pšikalová J, Řihák V, Snížek T, Reiterer P, Homolka J, Musilová P, Lněnička J, Palúch P, Hrdina R, Králová R, Hortvíková H, Strenková J, Vašáková M. Doubková M, et al. Among authors: lostakova v. Clin Respir J. 2018 Apr;12(4):1526-1535. doi: 10.1111/crj.12700. Epub 2017 Sep 26. Clin Respir J. 2018. PMID: 28862397
Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry.
Zurkova M, Kriegova E, Kolek V, Lostakova V, Sterclova M, Bartos V, Doubkova M, Binkova I, Svoboda M, Strenkova J, Janotova M, Plackova M, Lacina L, Rihak V, Petrik F, Lisa P, Bittenglova R, Tyl R, Ondrejka G, Suldova H, Lnenicka J, Psikalova J, Snizek T, Homolka J, Kralova R, Kervitzer J, Vasakova M; ILD section; IPF registry. Zurkova M, et al. Among authors: lostakova v. Respir Res. 2019 Jan 21;20(1):16. doi: 10.1186/s12931-019-0977-2. Respir Res. 2019. PMID: 30665416 Free PMC article.